BioBridge Global, a San Antonio-based 501(c)(3) nonprofit, integrates donor-to-patient services to enable the future of biotherapeutic solutions, including blood, tissue and advanced therapies.
Through its subsidiaries – South Texas Blood & Tissue, QualTex Laboratories and GenCure – BioBridge Global provides products and services in blood resource management, cellular therapy manufacturing, donated umbilical cord blood and human tissue, as well as testing of blood, plasma, tissue and cellular products for clients in the United States and international markets.
It supports the development of advanced therapies by providing access to starting materials, testing services, biomanufacturing and clinical trials support.
BioBridge Global is committed to saving and enhancing lives through the healing power of human cells and tissue. Learn more at BioBridgeGlobal.org.
You can also find us on Twitter at @BioBridgeGlobal.
|
|
|
|
|
201-500 employees
View all BioBridge Global employees
|
|
|
Biotechnology Research
|
|
|
(210) 757-9505
|
|
|
6211 W I-10, San Antonio, TX 78201, US
|
|
|
2013
|
|
|
Clinical Research, Microbiology, Process Development, Biomanufacturing, Immunohematology, Apheresis, Hospital Services, Research & Development, Advanced Therapies, Blood Collection, Starting Materials, Donor Screening, Clinical Manufacturing, Cord Blood Collection
|
Linda K Myers is the CEO of BioBridge Global.
The decision makers in BioBridge Global are Chris Johnson, Christie Loe Malone, Emmanuel Casasola, etc. Click to Find BioBridge Global decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.